# Kyndryl Holdings, Inc.

Type: Company (KD)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/kyndryl-holdings-inc
Canonical HTML page: https://getbiobrief.com/entity/kyndryl-holdings-inc

## Timeline

- **2026-Q3**: Anticipated Amended Complaint — Expected filing of detailed allegations following the appointment of lead plaintiffs.
- **2026-04-13**: Lead Plaintiff Deadline — Final date for eligible investors to file applications in the class action lawsuits against QURE and KD.
- **2026-02-18**: Legal Alert Issued — ClaimsFiler reminds shareholders of upcoming deadlines for lead plaintiff applications.

## Recent coverage (1 stories)

### uniQure and Kyndryl Face April Deadlines in Securities Class Action Lawsuits
2026-02-19 19:43:15 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Investors in uniQure N.V. and Kyndryl Holdings have until April 13, 2026, to file as lead plaintiffs in securities class action lawsuits following significant stock losses. The litigation highlights increasing regulatory and disclosure pressures on biotech firms specializing in complex gene therapies.
Full story: https://getbiobrief.com/story/uniqure-kyndryl-securities-class-action-deadlines

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.